EBioMedicine (Aug 2018)

Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19

  • Yinpeng Jin,
  • Junyi Wang,
  • Hongchao Li,
  • Shane Gao,
  • Rongfeng Shi,
  • Danjing Yang,
  • Xianli Wang,
  • Xi Wang,
  • Liang Zhu,
  • Xiaojin Wang,
  • Chengwei Chen,
  • Ke Ning,
  • Qingchun Fu,
  • Jun Xu,
  • Zhengliang Gao

Journal volume & issue
Vol. 34
pp. 231 – 242

Abstract

Read online

It has previously been reported that human adipose-derived stem cells (hASCs) can promote the regeneration of damaged tissues in rats with liver failure through a ‘paracrine effect’. Here we demonstrate a therapeutic effect of hASCs derived Extracellular Vesicles (EVs) on rat models with acute liver failure, as shown by the improvement of the survival rate by >70% compared to controls. Gene sequencing of rat liver revealed an increase in human long-chain non-coding RNA (lncRNA) H19 after hASC-derived EVs transplantation. When the H19 coding sequence was silenced in hASCs and EVs were then collected for treatment of rats with liver failure, we saw a decrease in the survival rate to 40%, compared to treatment with EVs generated from non-silenced hASCs. These data indicate that lncRNA H19 may be a potential therapeutic target for the treatment of liver failure. Keywords: Extracellular vesicles, Adipose-derived stem cells, Regeneration, Liver failure, LncRNA